eli lilly and company tirzepatide eyes cardio filings after late-stage win Lilly releases Zepbound® (tirzepatide) single-dose

While this is not overly present in the industry today, the prevalence of this prior authorization structure is increasing and could grow in popularity as the number of GLP-1 prescriptions increases

BCLC classification pre-ICI: 32.6% A3, 15.4% A4, 33.8% B, and 18.2% C

Impact on Reproductive Hormones and Menstrual Cycles Significant weight loss can influence estrogen and progesterone

Knowing your genetic predisposition helps your care team set realistic expectations for appetite suppression timing and adjust your dose strategy from the start

Do not double: missed doses need cautious handling

The role of GLP1 receptor agonists in adult-onset type 1 diabetes mellitus